BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 14749693)

  • 1. Lanreotide effect on splanchnic blood flow in healthy subjects: effect of the rate of infusion.
    Sieber CC; Beglinger C; Bart S; Tschoepl M; Currie G; Larsen F; Drewe J
    Clin Pharmacol Ther; 2004 Jan; 75(1):70-9. PubMed ID: 14749693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of the somatostatin analog lanreotide in humans: placebo-controlled, cross-over dose-ranging Echo-Doppler study.
    Mottet C; Sieber CC; Nauer A; Drewe J; Fried R; Larsen F; Beglinger C
    Hepatology; 1998 Apr; 27(4):920-5. PubMed ID: 9537429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the somatostatin analogue lanreotide on meal-stimulated portal blood flow in patients with liver cirrhosis.
    Schiedermaier P; Harrison P; Arthur M; Grandt D; Sutton R; Drewe J; Larsen F; Sieber C;
    Digestion; 2002; 65(1):56-60. PubMed ID: 11961344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency.
    Barbanoj M; Antonijoan R; Morte A; Grinyó JM; Solà R; Vallès J; Peraire C; Cordero JA; Muñoz A; Jané F; Obach R
    Clin Pharmacol Ther; 1999 Nov; 66(5):485-91. PubMed ID: 10579475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent gastrointestinal effects of the somatostatin analog lanreotide in healthy volunteers.
    Drewe J; Sieber CC; Mottet C; Wullschleger C; Larsen F; Beglinger C
    Clin Pharmacol Ther; 1999 Apr; 65(4):413-9. PubMed ID: 10223779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lanreotide, a somatostatin analogue, on postprandial gastric functions and biliopancreatic secretions in humans.
    Lamrani A; Vidon N; Sogni P; Nepveux P; Catus F; Blumberg J; Chaussade S
    Br J Clin Pharmacol; 1997 Jan; 43(1):65-70. PubMed ID: 9056054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profile of the somatostatin analogue lanreotide in individuals with chronic hepatic insufficiency.
    Tomlinson B; Thomas NG; Lan IW; Barbanoj M; Antonijoan RM; Drazna E; Ramis J; Obach R; Peraire C
    Clin Pharmacokinet; 2006; 45(10):1003-11. PubMed ID: 16984213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic analysis of lanreotide Autogel in healthy subjects : evidence for injection interval of up to 2 months.
    Trocóniz IF; Cendrós JM; Peraire C; Ramis J; Garrido MJ; Boscani PF; Obach R
    Clin Pharmacokinet; 2009; 48(1):51-62. PubMed ID: 19071884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Splanchnic hemodynamic effects of somatostatin and octreotide in cirrhotic patients. A Doppler ultrasonographic study].
    Fernández Pérez FJ; Jiménez Sáenz M; García Montes JM; Rebollo Bernárdez J; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 2008 Sep; 100(9):552-9. PubMed ID: 19025306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of dopexamine on postprandial splanchnic hyperaemia.
    Bartsch S; Brüning A; Reimann FM; Ludwig D
    Eur J Clin Invest; 2004 Apr; 34(4):268-74. PubMed ID: 15086358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of a new Autogel formulation of the somatostatin analogue lanreotide after a single subcutaneous dose in healthy volunteers.
    Antonijoan RM; Barbanoj MJ; Cordero JA; Peraire C; Obach R; Vallès J; Chérif-Cheikh R; Torres ML; Bismuth F; Montes M
    J Pharm Pharmacol; 2004 Apr; 56(4):471-6. PubMed ID: 15099442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term haemodynamic effects of octreotide on postprandial splanchnic hyperemia in humans: a placebo-controlled echo-doppler study.
    Ludwig D; Terai S; Brüning A; Stange EF
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1119-29. PubMed ID: 10468691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vasopressin on esophageal varices blood flow in patients with cirrhosis: comparisons with the effects on portal vein and superior mesenteric artery blood flow.
    Iwao T; Toyonaga A; Oho K; Shigemori H; Sakai T; Tayama C; Masumoto H; Sato M; Tanikawa K
    J Hepatol; 1996 Oct; 25(4):491-7. PubMed ID: 8912148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
    Kalambokis G; Economou M; Paraskevi K; Konstantinos P; Pappas C; Katsaraki A; Tsianos EV
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylephrine infusion versus bolus regimens during cesarean delivery under spinal anesthesia: a double-blind randomized clinical trial to assess hemodynamic changes.
    Doherty A; Ohashi Y; Downey K; Carvalho JC
    Anesth Analg; 2012 Dec; 115(6):1343-50. PubMed ID: 23011562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of postprandial hyperemia in superior mesenteric artery and portal vein in healthy and cirrhotic humans: an operator-blind echo-Doppler study.
    Sabbá C; Ferraioli G; Genecin P; Colombato L; Buonamico P; Lerner E; Taylor KJ; Groszmann RJ
    Hepatology; 1991 Apr; 13(4):714-8. PubMed ID: 2010166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study.
    Ludwig D; Schädel S; Brüning A; Schiefer B; Stange EF
    Dig Dis Sci; 2000 May; 45(5):1019-27. PubMed ID: 10795771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of endothelin and BQ123 on ocular blood flow parameters in healthy subjects.
    Polak K; Petternel V; Luksch A; Krohn J; Findl O; Polska E; Schmetterer L
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2949-56. PubMed ID: 11687541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of gender upon basal and postprandial systemic and splanchnic haemodynamics in humans.
    Szinnai C; Mottet C; Gutzwiller JP; Drewe J; Beglinger C; Sieber CC
    Scand J Gastroenterol; 2001 May; 36(5):540-4. PubMed ID: 11346210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of lanreotide effects on human exocrine pancreatic secretion after a single dose: preliminary study.
    Falconi M; Contro C; Ballabio M; Bassi C; Salvia R; Pederzoli P
    Dig Liver Dis; 2002 Feb; 34(2):127-32. PubMed ID: 11926556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.